Earnings History Data for Amneal Pharmaceuticals, Inc. (AMRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
02-05-2025	PM		AMRX	Amneal Pharmaceuticals, Inc.	2,370	0.19	0.14	0.12	Amneal Pharmaceuticals Non-GAAP EPS of $0.21 beats by $0.06, revenue of $695.4M misses by $20.09M [5/2/2025 6:09 AM]	7.98	0.24 (3.10%)	8.00	0.26 (3.36%)	5.81 - 9.48	3,321,363	1,840,000	189,609
Amneal Pharmaceuticals Q1 2025 Earnings Preview [5/1/2025 11:00 AM] Amneal Pharmaceuticals Non-GAAP EPS of $0.21 beats by $0.06, revenue of $695.4M misses by $20.09M [5/2/2025 6:09 AM] Amneal targets $3B-$3.1B in 2025 revenue with strong growth drivers [5/2/2025 11:32 AM] Amneal Reports First Quarter 2025 Financial Results [2025-05-02 06:00AM] Amneal Pharmaceuticals Inc (AMRX) Q1 2025 Earnings Report Preview: What To Expect [May-01-25 09:23AM]
28-02-2025	PM		AMRX	Amneal Pharmaceuticals, Inc.	2,610	0.10	0.13	0.12	Amneal Pharmaceuticals reports mixed Q4 earnings; initiates FY25 outlook [2/28/2025 6:02 AM]	8.67	0.29 (3.46%)	8.38	0.0 (0.00%)	5.01 - 9.48	2,424,823	1,570,000	18,161
Amneal Pharmaceuticals Q4 2024 Earnings Preview [2/27/2025 11:42 AM] Amneal Pharmaceuticals reports mixed Q4 earnings; initiates FY25 outlook [2/28/2025 6:02 AM] Amneal projects $3B-$3.1B revenue in 2025 with biosimilars and CREXONT as key drivers [2/28/2025 2:21 PM] Amneal Pharmaceuticals Inc (AMRX) Q4 2024: Everything You Need To Know Ahead Of Earnings [Feb-27-25 07:10AM] Amneal Reports Fourth Quarter and Full Year 2024 Financial Results [2025-02-28 06:00AM]
08-11-2024	PM		AMRX	Amneal Pharmaceuticals, Inc.	2,630	0.15	0.12	0.17	Amneal Pharmaceuticals Non-GAAP EPS of $0.16 beats by $0.02, revenue of $702.5M beats by $8.77M [11/8/2024 6:02 AM]	8.70	0.09 (0.99%)	8.22	-0.39 (-4.53%)	3.96 - 8.95	1,463,163	1,050,000	5,828
Amneal Pharmaceuticals Q3 2024 Earnings Preview [11/7/2024 12:11 PM] Amneal Pharmaceuticals Non-GAAP EPS of $0.16 beats by $0.02, revenue of $702.5M beats by $8.77M [11/8/2024 6:02 AM] Amneal Reports Third Quarter 2024 Financial Results [2024-11-08 06:00AM] Earnings To Watch: Amneal Pharmaceuticals Inc (AMRX) Reports Q3 2024 Result [Nov-07-24 07:04AM]
09-08-2024	PM		AMRX	Amneal Pharmaceuticals, Inc.	2,100	0.15	0.11	0.16	Amneal Pharmaceuticals beats top-line and bottom-line estimates; raises FY24 outlook [8/9/2024 6:08 AM]	7.64	-0.12 (-1.61%)	7.80	0.03 (0.39%)	3.36 - 8.15	3,037,649	1,310,000	44,705
Amneal Pharmaceuticals Q2 2024 Earnings Preview [8/8/2024 1:42 PM] Amneal Pharmaceuticals beats top-line and bottom-line estimates; raises FY24 outlook [8/9/2024 6:08 AM]
03-05-2024	PM		AMRX	Amneal Pharmaceuticals, Inc.	1,860	0.12	0.08	0.10	Amneal Pharmaceuticals Non-GAAP EPS of $0.14 beats by $0.05, revenue of $659M beats by $39.97M [5/3/2024 6:02 AM]	6.75	0.54 (8.62%)	6.42	0.21 (3.38%)	1.74 - 6.90	3,563,869	1,840,000	14,167
Amneal stock climbs on Q1 report, opioid settlement update [5/3/2024 3:45 PM] Amneal Pharmaceuticals Non-GAAP EPS of $0.14 beats by $0.05, revenue of $659M beats by $39.97M [5/3/2024 6:02 AM] Amneal Pharmaceuticals Q1 2024 Earnings Preview [5/2/2024 11:48 AM]
01-03-2024	PM		AMRX	Amneal Pharmaceuticals, Inc.	1,690	0.12	0.05	0.21	Amneal Pharmaceuticals Non-GAAP EPS of $0.14 beats by $0.05, revenue of $617M misses by $17.86M [3/1/2024 6:02 AM]	5.45	-0.07 (-1.27%)	6.00	0.48 (8.70%)	1.24 - 6.30	4,492,453	1,500,000	1,081,324
Amneal Pharmaceuticals Q4 2023 Earnings Preview [2/29/2024 11:17 AM] Amneal Pharmaceuticals Non-GAAP EPS of $0.14 beats by $0.05, revenue of $617M misses by $17.86M [3/1/2024 6:02 AM]
07-11-2023	PM		AMRX	Amneal Pharmaceuticals, Inc.	1,310	0.17	0.10	0.12	Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.06, revenue of $620M beats by $15.47M [11/7/2023 6:04 AM]	4.32	0.11 (2.55%)	4.46	0.25 (5.94%)	1.24 - 4.74	1,701,518	1,450,000	35,725
Amneal Pharmaceuticals Q3 2023 Earnings Preview [11/6/2023 11:32 AM] Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.06, revenue of $620M beats by $15.47M [11/7/2023 6:04 AM]
04-08-2023	PM		AMRX	Amneal Pharmaceuticals, Inc.	974.40	0.16	0.08	0.15	Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.09, revenue of $599M beats by $33.89M [8/4/2023 6:03 AM]	4.12	0.77 (22.77%)	3.60	0.24 (7.14%)	1.24 - 4.27	4,072,547	800,000	13,452
Amneal Pharmaceuticals Q2 2023 Earnings Preview [8/3/2023 2:20 PM] Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.09, revenue of $599M beats by $33.89M [8/4/2023 6:03 AM]
05-05-2023	PM	6:00 AM ET (May 5)	AMRX	Amneal Pharmaceuticals, Inc.	285.17	0.10	0.07	0.10	Amneal Pharmaceuticals Non-GAAP EPS of $0.12 beats by $0.02, revenue of $558M beats by $15.82M [5/5/2023 6:04 AM]	1.92	0.08 (4.21%)	1.81	-0.03 (-1.63%)	1.24 - 3.77	728,891	850,000	5,358
Amneal Pharmaceuticals Q1 2023 Earnings Preview [5/4/2023 12:40 PM] Amneal Pharmaceuticals Non-GAAP EPS of $0.12 beats by $0.02, revenue of $558M beats by $15.82M [5/5/2023 6:04 AM]
02-03-2023	PM	6:00 AM ET (Mar 2)	AMRX	Amneal Pharmaceuticals, Inc.	336.28	0.21	0.19	0.16	Amneal Pharmaceuticals Non-GAAP EPS of $0.23 beats by $0.02, revenue of $610M beats by $30.07M [3/2/2023 6:04 AM]	1.99	-0.10 (-5.02%)	2.10	0.01 (0.48%)	1.82 - 4.60	1,421,013	700,000	51,774
Amneal Pharmaceuticals Q4 2022 Earnings Preview [3/1/2023 12:54 PM] Amneal Pharmaceuticals Non-GAAP EPS of $0.23 beats by $0.02, revenue of $610M beats by $30.07M [3/2/2023 6:04 AM] Amneal stock rises ~15% on FDA review of Narcan generic, Q4 beat [3/2/2023 6:17 AM]
04-11-2022	PM	6:00 AM ET (Nov 4)	AMRX	Amneal Pharmaceuticals, Inc.	319.47	0.12	0.16	0.19	Amneal Pharmaceuticals Non-GAAP EPS of $0.14 misses by $0.04, revenue of $545.56M misses by $16.61M [11/4/2022 6:07 AM]	2.11	0.03 (1.44%)	2.08	0.0 (0.00%)	1.95 - 5.42	808,648	990,000	1,765
Amneal Pharmaceuticals Q3 2022 Earnings Preview [11/3/2022 1:22 PM] Amneal Pharmaceuticals Non-GAAP EPS of $0.14 misses by $0.04, revenue of $545.56M misses by $16.61M [11/4/2022 6:07 AM] Amneal Reports Third Quarter 2022 Financial Results [Nov-04-22 06:00AM] Select Medical (SEM) Q3 Earnings Miss Estimates [Nov-03-22 08:15PM] Amneal Pharmaceuticals (AMRX) Q3 Earnings and Revenues Lag Estimates [Nov-04-22 07:25AM]
05-08-2022	PM	6:00 AM ET (Aug 5)	AMRX	Amneal Pharmaceuticals, Inc.	476.55	0.15	0.18	0.23	Amneal Pharmaceuticals Non-GAAP EPS of $0.19 in-line, revenue of $559M beats by $24.56M, revises FY earning guidance [8/5/2022 6:04 AM]	3.18	-0.28 (-8.09%)	3.18	0.0 (0.00%)	2.90 - 5.99	1,789,169	660,000	728
Amneal Pharmaceuticals Q2 2022 Earnings Preview [8/4/2022 1:38 PM] Amneal Pharmaceuticals Non-GAAP EPS of $0.19 in-line, revenue of $559M beats by $24.56M, revises FY earning guidance [8/5/2022 6:04 AM] Amneal shares lower after generic drugmaker cuts FY 2022 profit outlook [8/5/2022 12:06 PM] Amneal Pharma Posts Mixed Q2 Earnings, Cuts Profit Outlook For 2022 [Aug-05-22 08:16AM] Amneal Pharmaceuticals (AMRX) Lags Q2 Earnings Estimates [Aug-05-22 07:25AM] Amneal Reports Second Quarter 2022 Financial Results [Aug-05-22 06:00AM]
04-05-2022	PM	6:00 AM ET (May 4)	AMRX	Amneal Pharmaceuticals	1,164	0.10	0.12	0.00	Amneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01, revenue of $497.63M misses by $4.66M [5/4/2022 6:05 AM]	3.73	-0.28 (-6.86%)	3.85	-0.16 (-3.99%)	3.26 - 6.21	2,505,315	640,000	7,830
Amneal Pharmaceuticals Q1 2022 Earnings Preview [5/3/2022 11:18 AM] Amneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01, revenue of $497.63M misses by $4.66M [5/4/2022 6:05 AM] Amneal falls 12% on disappointing Q1 result [5/4/2022 1:41 PM] Amneal Reports First Quarter 2022 Financial Results [May-04-22 06:00AM] Amneal Pharmaceuticals (AMRX) Q1 Earnings Meet Estimates [May-04-22 07:25AM]
02-03-2022	PM	6:00 AM ET (Mar 2)	AMRX	Amneal Pharmaceuticals, Inc.	676.65	0.16	0.17	0.11	Amneal Pharmaceuticals Non-GAAP EPS of $0.18 misses by $0.02, revenue of $537M beats by $3.59M [3/2/2022 6:02 AM]	4.04	-0.41 (-9.33%)	4.30	-0.15 (-3.37%)	3.89 - 7.45	1,537,047	450,000	6,722
Amneal Pharmaceuticals Q4 2021 Earnings Preview [3/1/2022 12:29 PM] Amneal Pharmaceuticals Non-GAAP EPS of $0.18 misses by $0.02, revenue of $537M beats by $3.59M [3/2/2022 6:02 AM] Amneal stock falls 8% following Q4 results; FY22 EPS outlook seen below estimates [3/2/2022 12:09 PM] Amneal Enters U.S. Biosimilars Market With Approval of RELEUKOTM (filgrastim-ayow) [Mar-01-22 04:05PM] Amneal Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-02-22 06:00AM] Amneal Pharmaceuticals (AMRX) Lags Q4 Earnings Estimates [Mar-02-22 07:25AM]
03-11-2021	PM	6:00 AM ET (Nov 3)	AMRX	Amneal Pharmaceuticals	1,670	0.19	0.20	0.00	Amneal Pharmaceuticals EPS beats by $0.01, misses on revenue [11/3/2021 6:01 AM]	5.30	-0.51 (-8.85%)	5.50	-0.32 (-5.50%)	3.90 - 7.45	1,665,983	700,000	9,841
Amneal Pharmaceuticals EPS beats by $0.01, misses on revenue [11/3/2021 6:01 AM] Amneal Pharmaceuticals Q3 2021 Earnings Preview [11/2/2021 10:25 AM] Amneal Reports Third Quarter 2021 Financial Results [Nov-03-21 06:00AM] Amneal Releases Inaugural Corporate Responsibility Report Highlighting Our Impact as a Socially Responsible Company [Nov-02-21 08:00AM] Amneal Pharmaceuticals (AMRX) Tops Q3 Earnings Estimates [Nov-03-21 07:25AM] Amneal Pharmaceuticals, inc (AMRX) Q3 2021 Earnings Call Transcript [Nov-03-21 04:01PM]
09-08-2021	PM	6:00 AM ET (Aug 9)	AMRX	Amneal Pharmaceuticals, Inc.	748.06	0.23	0.18	0.10	Amneal Pharmaceuticals EPS beats by $0.06, beats on revenue [8/9/2021 6:03 AM]	5.14	0.27 (5.54%)	5.15	0.28 (5.75%)	3.45 - 7.45	1,549,183	730,000	6,703
Amneal Pharmaceuticals EPS beats by $0.06, beats on revenue [8/9/2021 6:03 AM] Amneal Reports Second Quarter 2021 Financial Results [Aug-09-21 06:00AM] Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Top Estimates [Aug-09-21 07:25AM] Amneal Pharmaceuticals, inc (AMRX) Q2 2021 Earnings Call Transcript [Aug-09-21 01:30PM]
07-05-2021	PM	6:00 AM ET (May 7)	AMRX	Amneal Pharmaceuticals, Inc.	847.52	0.19	0.17	0.18	Amneal Pharmaceuticals EPS beats by $0.02, misses on revenue [5/7/2021 6:06 AM]	5.20	-0.58 (-10.03%)	5.20	0.0 (0.00%)	3.44 - 7.45	2,375,046	970,000	961
Amneal Pharmaceuticals Q1 2021 Earnings Preview [5/6/2021 11:47 AM] Amneal Pharmaceuticals EPS beats by $0.02, misses on revenue [5/7/2021 6:06 AM] Amneal Reports First Quarter 2021 Financial Results [May-07-21 06:00AM] Amneal Pharmaceuticals, Inc. to Host Earnings Call [May-07-21 06:45AM] Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates [May-07-21 07:30AM] Amneal Pharmaceuticals, Inc. (AMRX) Q1 2021 Earnings Call Transcript [May-07-21 06:00PM]
26-02-2021	PM	6:00 AM ET (Feb 26)	AMRX	Amneal Pharmaceuticals, Inc.	708.62	0.11	0.12	0.07	Amneal Pharmaceuticals EPS beats by $0.01, beats on revenue [2/26/2021 6:05 AM]	5.44	0.55 (11.25%)	5.00	0.11 (2.25%)	2.40 - 6.18	4,109,256	1,384,050	22,277
Amneal Pharmaceuticals EPS beats by $0.01, beats on revenue [2/26/2021 6:05 AM] Amneal Pharmaceuticals Q4 2020 Earnings Preview [2/25/2021 12:00 PM] Amneal wins FDA nod for generic version of Ortho Evra [2/26/2021 7:23 AM] Amneal shares rise after Q4 results, FY forecast [2/26/2021 8:08 AM] Amneal Pharmaceuticals (AMRX) Surpasses Q4 Earnings and Revenue Estimates [Feb-26-21 07:30AM] Amneal Pharmaceuticals, Inc. to Host Earnings Call [Feb-26-21 06:30AM] Amneal Receives Approval for Generic Version of Ortho Evra® [Feb-26-21 06:02AM] Amneal Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-26-21 06:00AM] A Preview Of Amneal Pharmaceuticals's Earnings [Feb-25-21 10:04AM]
06-11-2020	PM	6:00 AM ET (Nov 6)	AMRX	Amneal Pharmaceuticals, Inc.	708.19	0.13	0.12	0.00	Amneal Pharmaceuticals EPS beats by $0.04, beats on revenue [11/6/2020 6:01 AM]	4.12	-0.80 (-16.33%)	4.99	0.06 (1.22%)	2.40 - 5.79	2,640,012	1,411,449	29,264

06-08-2020	PM	6:30 AM ET (Aug 6)	AMRX	Amneal Pharmaceuticals, Inc.	1,410	0.10	0.10	0.06	Amneal Pharmaceuticals EPS beats by $0.03, beats on revenue [8/6/2020 6:06 AM]	4.63	-0.64 (-12.14%)	4.54	-0.73 (-13.85%)	2.27 - 5.79	1,802,723	1,226,651	73,460